Alphatec Holdings Stock News

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in

Alphatec Holdings Inc (ATEC) shares closed today 12.8% higher than it did at the end of yesterday. The stock is currently down 1.1% year-to-date, down 15.5% over the past 12 months, and up 220.1% over the past five years. Today, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $12.33 and as low as $11.27 this week.Shares closed 34.1% below its 52-week high and 23.7% above its 52-week low.Trading volume this week was 29.3% lower than the 10-day average and 39.8% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 119.1% The company's stock price performance over the past 12 months lags the peer average by 200.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Analysts expect Alphatec Holdings, Inc. (NASDAQ:ATEC) to report $66.59 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Alphatecs earnings. The lowest sales estimate is $65.67 million and the highest is $68.00 million. Alphatec posted sales of $43.95 million during the same quarter last year, which would []

Alphatec Holdings, Inc. (NASDAQ:ATEC) Director Jason Hochberg acquired 5,000 shares of the companys stock in a transaction dated Wednesday, December 15th. The shares were bought at an average cost of $10.84 per share, for a total transaction of $54,200.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can []

Alphatec Holdings, Inc. (NASDAQ:ATEC) Director James L. L. Tullis sold 20,000 shares of the companys stock in a transaction that occurred on Thursday, December 9th. The shares were sold at an average price of $11.78, for a total transaction of $235,600.00. The sale was disclosed in a legal filing with the SEC, which is accessible []

Perkins Capital Management Inc. trimmed its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 2.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 171,600 shares of the medical technology companys stock after selling 5,150 shares during the quarter. Alphatec makes up about 1.3% of Perkins Capital Management Inc.s portfolio, making the stock its []

Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) have received an average recommendation of Buy from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company. The []

The Goldman Sachs Group started coverage on shares of Alphatec (NASDAQ:ATEC) in a report issued on Friday, Price Targets.com reports. The firm issued a neutral rating and a $12.50 price target on the medical technology companys stock. Several other research firms also recently commented on ATEC. Loop Capital assumed coverage on shares of Alphatec in []

Research analysts at The Goldman Sachs Group initiated coverage on shares of Alphatec (NASDAQ:ATEC) in a report issued on Friday, The Fly reports. The brokerage set a neutral rating and a $12.50 price target on the medical technology companys stock. The Goldman Sachs Groups target price would indicate a potential upside of 13.12% from the []

Brokerages expect Alphatec Holdings, Inc. (NASDAQ:ATEC) to announce earnings per share (EPS) of ($0.30) for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Alphatecs earnings. The lowest EPS estimate is ($0.37) and the highest is ($0.27). Alphatec posted earnings of ($0.22) per share in the same quarter last []

Alphatec Holdings, Inc. (NASDAQ:ATEC) major shareholder Paul Segal purchased 67,496 shares of Alphatec stock in a transaction that occurred on Tuesday, November 23rd. The shares were acquired at an average price of $10.09 per share, with a total value of $681,034.64. The purchase was disclosed in a legal filing with the SEC, which is available [] The post Alphatec Holdings, Inc. (NASDAQ:ATEC) Major Shareholder Buys $681,034.64 in Stock appeared first on ETF Daily News .

Wall Street analysts forecast that Alphatec Holdings, Inc. (NASDAQ:ATEC) will post $66.59 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Alphatecs earnings. The lowest sales estimate is $65.67 million and the highest is $68.00 million. Alphatec reported sales of $43.95 million during the same quarter last year, []

This Mini-invasive Orthopedic Surgery Systems market report''s major objective is to evaluate, outline, and predict the various kinds, applications, makers, and regions. The research goes into great detail on the key variables driving growth in the economy (drivers, limitations, possibilities,

Alphatec Holdings, Inc. (NASDAQ:ATEC) Director David R. Pelizzon purchased 4,366 shares of the companys stock in a transaction dated Thursday, November 11th. The shares were bought at an average price of $11.41 per share, for a total transaction of $49,816.06. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which []

Alphatec Holdings, Inc. (NASDAQ:ATEC) SVP Scott Lish sold 6,250 shares of the stock in a transaction dated Wednesday, November 10th. The stock was sold at an average price of $11.79, for a total transaction of $73,687.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the []